Skip to main content

Table 2 Preoperative patient demographics in eyes undergoing either method of phakic intraocular Lens (PIOL) implantation

From: A novel ophthalmic viscosurgical device-free phakic intraocular lens implantation makes myopic surgery safer

DemographicOVD-free methodStandard methodP value
Age (SD), year28.50 (3.97)26.81 (6.04)0.243
Sex (%, female)50.0%85.7%0.009
SE (SD), D−13.09 (3.26)− 13.49 (3.27)0.676
AL (SD), mm28.53 (1.62)28.15 (1.73)0.439
UDVA (IQR), logMAR1.22 (1.02–1.40)1.30 (1.16–1.40)0.342
CDVA (IQR), logMAR0.10 (0–0.15)0.15 (0.05–0.30)0.103
ACD (IQR), mm3.59 (3.46–3.81)3.73 (3.64–3.78)0.084
CCT (IQR), μm538.5 (518.0–564.8)523.0 (492.5–560.0)0.196
ECD (IQR), cells/mm22620.6 (2431.9–2983.9)2620.6 (2490.7–2963.0)0.664
IOP (IQR), mmHg14.45 (12.65–15.95)15.10(13.80–17.40)0.122
PIOL Power (SD), D−13.88 (2.78)−14.93(2.18)0.158
  1. OVD = Ophthalmic Viscosurgical Device; SE = Spherical equivalent; AL = Axial length; UDVA = Uncorrected distance visual acuity; CDVA = Corrected distance visual acuity; ACD = Anterior chamber depth; CCT = Center corneal thickness; ECD = Endothelial cell density; IOP = Intraocular pressure; SD = Standard deviation; IQR = Interquartile range